Clinical Outcome of Female Non-gastric Gastrointestinal Stromal Tumor

Status Completed

Clinical Trial Summary

To elucidate the prognosis of women with non-gastric primary gastrointestinal stromal tumors.

Clinical Trial Description

Gastrointestinal stromal tumor (GIST) are mesenchymal tumors arising from gastrointestinal tract, mesentery, or omentum. They took up about 3% of gastrointestinal malignancies. Although rarely, the clinical presentation of non-gastric GIST might mimick ovarian cancer, and would be managed by gynecologists. Therefore, retrospective review of female non-gastric GIST cases will be performed to investigate the clinical outcome of non-gastric GIST. The result of this study might be used as an important reference for gynecologists. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04256226
Study type	Observational
Source	Far Eastern Memorial Hospital
Contact
Status	Completed
Phase
Start date	February 1, 2020
Completion date	March 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04933669` - Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors	Phase 2
Completed	`NCT01769248` - Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle	N/A
Completed	`NCT01774162` - EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration	N/A
Completed	`NCT01110668` - Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)	Phase 2
Terminated	`NCT00091078` - Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery	Phase 2
Completed	`NCT00025246` - Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery	Phase 2
Active, not recruiting	`NCT00265798` - Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate	Phase 2
Recruiting	`NCT04143048` - A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules
Recruiting	`NCT02931981` - Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor	N/A
Not yet recruiting	`NCT02576080` - Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index	Phase 3
Recruiting	`NCT01389583` - A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients	Phase 2
Recruiting	`NCT00777504` - Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors	Phase 4
Completed	`NCT00764595` - Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor	Phase 2
Completed	`NCT00769782` - Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor	Phase 2
Completed	`NCT00098579` - Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery	Phase 1
Completed	`NCT00005862` - SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas	Phase 2
Completed	`NCT00004895` - Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	Phase 2
Recruiting	`NCT02776878` - A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST	N/A
Completed	`NCT01751919` - A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)	Phase 1
Completed	`NCT01267695` - Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor	Phase 2